Ultimovacs ASA reported unaudited consolidated financial results for the second quarter and six months ended June 30, 2021. For the quarter, the company reported operating profit of NOK 39,171,000 compared to NOK 36,183,000 for the same period of last year. Loss for the period was NOK 36,465,000 compared to NOK 34,909,000 for the same period of last year. Diluted and undiluted loss per share was NOK 1.1 compared to NOK 1.2 for the same period of last year. For the six months, the company reported operating profit of NOK 70,386,000 compared to NOK 67,442,000 for the same period of last year. Loss for the period was NOK 70,262,000 compared to NOK 65,245,000 for the same period of last year. Diluted and undiluted loss per share was NOK 2.2 compared to NOK 2.3 for the same period of last year.